Distribution of P2Y receptor subtypes on haematopoietic cells
about
Ca(2+) signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cellsInternational Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapyP2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cellsPurinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responsesHuman monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidasesSignal transduction and white cell maturation via extracellular ATP and the P2Y11 receptorPurinergic receptors activating rapid intracellular Ca increases in microglia.Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.Molecular mechanism of nucleotide-induced primary granule release in human neutrophils: role for the P2Y2 receptor.Purinergic regulation of neutrophil chemotaxis.P2 receptors: new potential players in atherosclerosisPKCbetaI mediates the inhibition of P2Y receptor-induced inositol phosphate formation in endothelial cells.Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms.Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.Involvement of P2Y receptors in the differentiation of haematopoietic cells.Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X7-associated pore or channel formation.Ectonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.The UDP-sugar-sensing P2Y(14) receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils.Intestinal alkaline phosphatase inhibits the proinflammatory nucleotide uridine diphosphateP2Y2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells.P2 receptor subtypes in the cardiovascular system.Chemotactic activity of extracellular nucleotideson human immune cells.P2 purinergic receptor modulation of cytokine production.CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors.Concomitant activation of P2Y(2) and P2Y(6) receptors on monocytes is required for TLR1/2-induced neutrophil migration by regulating IL-8 secretion.Extracellular nucleotides mediate LPS-induced neutrophil migration in vitro and in vivo.Lung injury during LPS-induced inflammation occurs independently of the receptor P2Y1.The P2Y2 nucleotide receptor interacts with alphav integrins to activate Go and induce cell migration.Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coliNucleotides regulate secretion of the inflammatory chemokine CCL2 from human macrophages and monocytes.ADP and other metabolites released from Acanthamoeba castellanii lead to human monocytic cell death through apoptosis and stimulate the secretion of proinflammatory cytokines.Nucleotidase cascades are catalyzed by secreted proteins of the parasitic nematode Trichinella spiralisP2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide.A miniature Couette to generate shear for flow cytometry: studying real-time modulation of intracellular calcium in monocytic cells.Regulation of innate immunity by extracellular nucleotidesP2Y(2) nucleotide receptor signaling in human monocytic cells: activation, desensitization and coupling to mitogen-activated protein kinases.P2X purinergic receptor channel expression and function in bovine aortic endothelium.Conformational regulation of alpha 4 beta 1-integrin affinity by reducing agents. "Inside-out" signaling is independent of and additive to reduction-regulated integrin activation.Real-time analysis of very late antigen-4 affinity modulation by shear.Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
P2860
Q24292394-AB05D97B-BF98-4782-BB7D-BD432CF4B8ADQ24629255-4DD9763A-E190-4534-9F1A-1D5F3341A621Q24799571-92EFFBFD-1240-4005-A582-DBF601D6819CQ26863398-EDE0E1C5-4A6C-46B3-B5E5-6FC2A5EFC47BQ28138370-151D9E14-EB31-40FE-A3EE-1E3B8013A259Q28144030-BD9F167C-0520-466A-A1CF-A07F98B9000CQ30477110-D97103AC-DCF7-4820-B8C4-5666F30E16C0Q33257485-18DD8D16-66AF-4C06-937E-CA854D0C4922Q34276269-CBC4AE2E-E33D-493B-B983-E1651E08EF15Q34425713-070F18A4-0463-494A-9B15-AA29E0FE2B4DQ34542194-A5FF46FF-77D0-499B-8A3C-06BBEED1D0E6Q35029215-624C47EB-4193-406E-9DB5-F27ECE0F4B97Q35045752-43AE8382-27E1-45B6-8D2C-845200E7FAB7Q35046009-A1D01007-B442-44FE-BEAC-1A922882842BQ35093125-CB06CCFC-1656-42BE-B081-51BBEBD93CADQ35545223-4D892BD2-3FCD-431A-ADD1-8AE6A6A1578BQ36071796-389FBDFC-26BC-45A3-A3EE-75A0D72456A4Q36308957-2EF8F8C8-D4AE-4BAB-ABA0-A81DFB23D4E9Q36699737-F192978B-DCBE-4F5A-A35F-A15CDEB2170DQ36733684-B2A08E91-FF18-434C-A634-161C8D1326F9Q36899623-B0718E27-246A-4940-92C9-9E5AD07ABAE8Q37135487-0C009865-BC9E-4D71-B2AE-07776D597115Q37135491-5064402A-A4DE-4DC6-BC25-18C59D6FE57CQ37140406-1F6F5053-EA13-451F-ACAE-900146A03AB9Q37478487-8724283D-3FDD-4690-BCAB-ED2841BB70FFQ37588542-448C85A8-39C8-46DC-A19F-C194FD829BCFQ37677822-6886F794-166D-4589-A007-6734CF5F0F1BQ38320628-1D898F14-9226-4169-90D3-FC46664C8CFAQ38751619-2A242B0F-74FA-460B-AE98-AF1E9AA78F06Q38951221-5C7A7852-42B6-439C-9204-13AAC437E396Q39655709-86789B39-E16C-44ED-BA42-E6AA85BF77A9Q39656271-CC17F1FF-0A99-41B3-80C1-A034AFC0B53BQ40806805-B5B6AA0D-D707-45F3-AC7F-866199AAA7FFQ41862732-C8358BBB-E66A-4301-A226-3D4923A0984DQ42252932-AA28C32A-7FFF-4443-8ACE-29BE60A13233Q43553572-B9C0D9F5-3935-4766-B4BE-75FDAC3CB22BQ43988574-6258C152-BFDA-4F27-84B2-949DF03D9610Q44912917-1C70C5D6-A7C7-4E48-9930-3BEB8310741EQ44958663-0386191D-DD03-4179-8C1E-2612E1E5F79EQ47151276-9E3F21E3-0FEE-4E88-BB65-5187156B36C4
P2860
Distribution of P2Y receptor subtypes on haematopoietic cells
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
Distribution of P2Y receptor subtypes on haematopoietic cells
@ast
Distribution of P2Y receptor subtypes on haematopoietic cells
@en
Distribution of P2Y receptor subtypes on haematopoietic cells
@nl
type
label
Distribution of P2Y receptor subtypes on haematopoietic cells
@ast
Distribution of P2Y receptor subtypes on haematopoietic cells
@en
Distribution of P2Y receptor subtypes on haematopoietic cells
@nl
prefLabel
Distribution of P2Y receptor subtypes on haematopoietic cells
@ast
Distribution of P2Y receptor subtypes on haematopoietic cells
@en
Distribution of P2Y receptor subtypes on haematopoietic cells
@nl
P2093
P356
P1476
Distribution of P2Y receptor subtypes on haematopoietic cells
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0701665
P407
P577
1998-03-01T00:00:00Z